EXCLOZA 100mg x 50 tabl
Treatment of treatment-resistant schizophrenia Clozapine is indicated in patients with treatment-resistant schizophrenia and in patients with schizophrenia who have severe, refractory neurological adverse reactions to other antipsychotics, including atypical antipsychotics. Treatment resistance is defined as the lack of satisfactory clinical improvement despite the use of appropriate doses of at least two different antipsychotics, including an atypical antipsychotic, prescribed for a sufficient period of time. Psychosis in Parkinson's disease Clozapine is also indicated in psychotic disorders arising in the course of Parkinson's disease in cases where standard treatment has been ineffective.